Search results :

2-hydroxysuccinaldehyde

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Code: B03XA01

Side effects

Options: Hide MedDRA Preferred Terms

MedDRA Preferred Term Side effect Data for drug Placebo Labels
1
Nausea Nausea 35% - 56% 30% - 45% x
Body temperature increased Body temperature increased 10.1% - 42% 8.3% - 34% x
Vomiting Vomiting 12% - 28% 14% - 16% x
Pruritus Pruritus 12% - 21% 14% x
Arthralgia Arthralgia 10% - 16.2% 3.1% - 7.6% x
Musculoskeletal discomfort Arthralgia 10% - 16.2% 3.1% - 7.6% x
Myalgia 10% 5% x
Injection site pain Injection site pain 9% - 13% 8% x
Headache Headache 5% - 18% 4% - 9% x
Stomatitis Stomatitis 10% 8% x
Myalgia Myalgia 10% 5% x
Dizziness Dizziness 9.5% 8.3% x
Weight decreased Weight decreased 9% 5% x
Thrombosis in device Artificial kidney clotting during dialysis 8.1% 4.2% x
Vascular occlusion Vascular occlusion 8.1% 2.1% x
Device malfunction Device malfunction 8.1% 4.2% x
Leukopenia Leukopenia 8% 7% x
Muscle spasms Muscle spasms 7.4% 6.3% x
Bone pain Bone pain 7% 4% x
Injection site irritation Injection site irritation 7% 4% x
Upper respiratory tract infection Upper respiratory tract infection 6.8% 5.2% x
Thrombosis Thrombosis 5% - 8.1% 2.1% - 3% x
Hyperglycaemia Hyperglycaemia 6% 4% x
Insomnia Insomnia 6% 2% x
Hypertension Hypertension 3% - 27.7% 5% - 12.5% x
Dysphagia Dysphagia 5% 2% x
Depression Depression 5% 4% x
Hypokalaemia Hypokalaemia 5% 3% x
Cough Cough 4% - 26% 0% - 14% x
Dermatitis Rash 2% - 19% 1% - 7% x
Rash Rash 2% - 19% 1% - 7% x
Urticaria Urticaria 3% 1% x
Chills Chills 0% - 7% 1% x
Oedema Oedema 1% - 3% 2% x
Deep vein thrombosis Deep vein thrombosis 0% - 6% 3% x
Pulmonary embolism Pulmonary embolism 1% x
Respiratory tract congestion Respiratory tract congestion 1% x
Anaemia Anaemia postmarketing x
Secondary anemia x
Pancytopenia Cytopenia postmarketing x
Hypersensitivity Hypersensitivity postmarketing x
Pain Pain postmarketing x
Porphyrin metabolism disorder Porphyrin metabolism disorder postmarketing x
Convulsion Convulsion postmarketing x
Injection site reaction Injection site reaction postmarketing x
Myocardial infarction Myocardial infarction x
Acute coronary syndrome Myocardial infarction x
Cerebrovascular accident Cerebrovascular accident x
Embolism Thromboembolism x
Embolism venous Thromboembolism x
Erythema Erythema x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

Erythropoietin

Side effects:46
Source:FDA Structured Product Label

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label